Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Society guideline links: Classic and nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Deputy Editors
Kathryn A Martin, MD
Alison G Hoppin, MD


This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Adrenal insufficiency" and "Society guideline links: Polycystic ovary syndrome" and "Society guideline links: Hirsutism".)

United States

Congenital Adrenal Hyperplasia Research, Education, and Support (CARES) Foundation Initiative: Guidelines for the development of comprehensive care centers for congenital adrenal hyperplasia (2010)

Endocrine Society (ES): Clinical practice guideline on congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency (2010)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Oct 2017. | This topic last updated: Jun 15, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.